Takeshi Azuma
Takeshi Azuma publishes mostly in Surgery, Pulmonary and Respiratory Medicine and Molecular Biology, on topics such as Helicobacter pylori-related gastroenterology studies, Gastric Cancer Management and Outcomes and Galectins and Cancer Biology.
- World rank
- #822,885 of 7,710,434 ranked researchers
- Rank in Japan
- #10,237 of 383,136
- Works
- 707
- Citations
- 22k
- Citations per work
- 31.7
What does Takeshi Azuma research?
Takeshi Azuma's work is mostly in Medicine (45%), Biochemistry, Genetics and Molecular Biology (9%), Immunology and Microbiology (6%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences31945.1%
- Medicine31945.1%
- Everything else28139.7%
- Life Sciences10715.2%
- 1Surgery24% of their works
- 2Pulmonary and Respiratory Medicine10% of their works
- 3Molecular Biology9% of their works
- 4Immunology6% of their works
- 5Epidemiology6% of their works
- 6Oncology6% of their works
Research topics
- Helicobacter pylori-related gastroenterology studies
- Gastric Cancer Management and Outcomes
- Galectins and Cancer Biology
- Eosinophilic Esophagitis
- Pancreatic and Hepatic Oncology Research
- Pancreatitis Pathology and Treatment
- Esophageal Cancer Research and Treatment
- Gastrointestinal Tumor Research and Treatment
Which keywords describe Takeshi Azuma's research?
The keywords of their largest research topics: Gastric Cancer, Inflammation, Antibiotic Resistance, Helicobacter pylori, Chemotherapy, Endoscopic Resection, Epidemiology and Lymph Node Dissection.
- Sunitinib
- Preoperative Chemoradiotherapy
- Chronic Pancreatitis
- Surgical Complications
- Eosinophilic Esophagitis
- Immune Regulation
- Neoadjuvant Therapy
- Lymph Node Dissection
- Endoscopic Resection
- Helicobacter pylori
- Inflammation
- Gastric Cancer
- Antibiotic Resistance
- Chemotherapy
- Epidemiology
- Molecular Characterization
- Galectins
- Diagnosis
- Pancreatic Cancer
- Acute Pancreatitis
- Esophageal Carcinoma
- Imatinib Mesylate
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 22 words, with their numbers
- Gastric Cancer2712 topics
- Inflammation2362 topics
- Antibiotic Resistance1811 topic
- Helicobacter pylori1811 topic
- Chemotherapy1302 topics
- Endoscopic Resection1272 topics
- Epidemiology1183 topics
- Lymph Node Dissection901 topic
- Molecular Characterization901 topic
- Neoadjuvant Therapy772 topics
- Galectins551 topic
- Immune Regulation551 topic
- Diagnosis441 topic
- Eosinophilic Esophagitis441 topic
- Pancreatic Cancer401 topic
- Surgical Complications401 topic
- Acute Pancreatitis371 topic
- Chronic Pancreatitis371 topic
- Esophageal Carcinoma371 topic
- Preoperative Chemoradiotherapy371 topic
- Imatinib Mesylate321 topic
- Sunitinib321 topic
Where does Takeshi Azuma work?
Takeshi Azuma's main affiliation in the publication record is Kobe University, Japan.
How many publications and citations does Takeshi Azuma have?
OpenAlex counts 707 works and 22,435 citations for Takeshi Azuma, an h-index of 78, ranking #822,885 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Takeshi Azuma. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.